
He has already been named Denmark’s most popular top-exec by major investors and the world’s 16th best top-exec by Fortune Magazine, and now Lars Rebien of Novo Nordisk has also made it into Harvard Business Review’s list of the top-100 business leaders.
More specifically he is number 20, and that place has been secured through an increase in the market value of the company of 64 billion dollars during his reign and a dividend to share holders of 470 %, among other factors.
Allerede abonnent? Log ind.
Læs hele artiklen
Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
- Adgang til alle låste artikler
- Modtag vores daglige nyhedsbreve
- Fuld adgang til vores app